The US Food and Drug Administration has given marketing authorization to Q30 Sports Science’s Q-Collar device, which is intended to reduce traumatic brain injury (TBI).
On 26 February, the agency announced that it had given the nod to Q30’s de novo application for the device’s use in children as young as 13 to protect their brains from the effects of repetitive sub-concussive head impacts
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?